Drug Shortage Report for PDP-LEVETIRACETAM
Report ID | 132789 |
Drug Identification Number | 02490447 |
Brand name | PDP-LEVETIRACETAM |
Common or Proper name | PDP-LEVETIRACETAM ORAL SOL. |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | LEVETIRACETAM |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL |
Packaging size | 300mL |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-02-02 |
Actual start date | 2021-02-02 |
Estimated end date | 2021-03-26 |
Actual end date | 2021-04-21 |
Shortage status | Resolved |
Updated date | 2021-04-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-04-22 | French | Compare |
v8 | 2021-04-22 | English | Compare |
v7 | 2021-04-22 | French | Compare |
v6 | 2021-04-22 | English | Compare |
v5 | 2021-02-12 | French | Compare |
v4 | 2021-02-12 | English | Compare |
v3 | 2021-02-03 | English | Compare |
v2 | 2021-01-29 | French | Compare |
v1 | 2021-01-29 | English | Compare |
Showing 1 to 9 of 9